This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked LSM1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-LSM1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~15.2 kDa | |
| Gel | 15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A05573 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Hela, HEK293T (catalog A05573) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A05573; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
LSM1 is predicted at 15.2 kDa; its annotated phosphorylation sites may affect migration, but no empirical band size or visible shift is established.
| Single band near 15.2 kDa | Consistent with predicted LSM1 size; identity needs confirmation |
| Closely spaced bands near 15.2 kDa | Could reflect phosphorylation at Ser123 or Thr129, but separation is unproven |
| Band near 15.2 kDa in whole-cell lysate | Consistent with cytoplasmic LSM1 |
| No band near 15.2 kDa in whole-cell lysate | Cytoplasmic localization does not explain its absence; check detection and identity |
| UniProt predicted mass | Places the expected band near 15.2 kDa |
| Phosphoserine at Ser123 | A distinct apparent size shift is not established |
| Phosphothreonine at Thr129 | A distinct apparent size shift is not established |
| Cytoplasmic P-body localization | Does not establish an apparent size change |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoplasmic localization does not account for absence from whole-cell lysate | Check loading and antibody detection; use an LSM1 depletion control |
| Band higher than expected | No supplied feature establishes a large upward shift | Check molecular-weight calibration and test band identity by LSM1 depletion |
| Band lower than expected | No signal peptide or propeptide cleavage is annotated | Check sample integrity and test band identity by LSM1 depletion |
| Multiple bands | Phosphorylation at Ser123 or Thr129 could contribute, but distinct bands are unproven | Compare phosphatase-treated material and an LSM1 depletion control |
| Weak or no signal | The supplied features do not establish a cause | Check loading, transfer, and antibody detection with appropriate controls |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for LSM1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three anti-LSM1 antibodies have WB images. A05573 shows HeLa and HEK293T lysates at 1:500; A05573-2 shows K562 lysate at 1:1000. A05573-1 reports various cell lines at 1:3000 without naming them. These captions do not establish mouse WB validation.
Which to pick: For HeLa or HEK293T, consider A05573; for K562, consider A05573-2. All three have WB images. A05573-1 and A05573-2 list Human and Mouse reactivity, but their supplied captions do not identify a mouse sample.